BI-204
Blow for BioInvent as vascular treatment fails
July 11, 2012Research and Development, Sales and Marketing BI-204, BioInvent, LDL, Sweden
Swedish biotech company BioInvent has suffered a new blow with the failure of its lead pipeline candidate. The company’s share …
Latest content
Medtronic secures CE Mark for new cardiac pacing portfolio
October 30, 2026
Dermatology leader Doncker is new Onicor CEO
October 29, 2026
October 28, 2026
